It’s time to consider a patent reprieve for COVID vaccines

Nature
Volume 592 Issue 7852, 1 April 2021
https://www.nature.com/nature/volumes/592/issues/7852

 

Editorial | 30 March 2021
It’s time to consider a patent reprieve for COVID vaccines
The pandemic is not a competition between companies and will not end without more-equal distribution of coronavirus vaccines.